News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week In Review: China Pharma Continues Record Deal Pace With $2 Billion In New Announcements



9/11/2017 11:20:21 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Deals and Financings

- OrbiMed closed its third Asia private equity fund with $551 million in capital commitments, bringing its three Asia funds to almost $1 billion in total;

- Innovent Biologics of Suzhou announced a $457 million deal to acquire global rights for an immuno-therapy candidate from the Chinese Academy of Sciences;

- 3SBio of Shenyang will pay $290 million for the biologic contract development and manufacturing operations of Toronto's Therapure;

- Eight Roads, Fidelity Investment's venture arm, launched a $250 million China Healthcare Fund, its first fund dedicated to China healthcare;

- WuXi NextCODE completed a Series B fundraising with $240 million in new capital for its genomics CRO operations;

- Sisram Medical, an Israeli subsidiary of Fosun Pharma that makes laser-based aesthetic devices, will stage a $200 million Hong Kong IPO;

- Beijing's SinoVision Technologies raised $29 million in a B round to support its portfolio of CT scanners;

- Shanghai Sanyou Medical, an orthopedic medical device maker, closed a $14 million B round from Yingke Private Equity;

- China Medical Systems of Shenzhen will gain Asia rights (ex-Japan) to a MRSA candidate from Destiny Pharma, a British company;

- TPG Capital Asia acquired a majority stake in OPC Holding Company, a Taiwan company that provides clinical trial services in China and southeast Asia;

- Wuxi Fortune Pharma partnered with Andarix Pharma of Boston for China development of Tozaride, a radiolabeled cancer drug candidate;

Company News

- Lilly China notified its staff members that Lilly will close its five-year-old Shanghai R&D center, which has 200 employees, as part of a major company restructuring.

Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES